培养与宏基因组分析揭示银屑病皮肤微生物组显著变化
该前瞻性观察研究对23例银屑病患者皮损与非皮损部位及20例健康对照的皮肤拭子,采用16S rRNA测序和传统培养联合MALDI-TOF质谱分析皮肤微生物组。结果显示银屑病与厚壁菌门丰度增加、放线菌门减少相关,皮损处最明显且系统治疗可部分逆转;普雷沃菌属和葡萄球菌属与皮损显著相关,而厌氧球菌属和丙酸杆菌属与非皮损相关。
要点
- 银屑病皮损处厚壁菌门增加、放线菌门减少,系统治疗可部分逆转。
- 普雷沃菌属和葡萄球菌属与皮损显著相关,厌氧球菌属和丙酸杆菌属与非皮损相关。
- 培养与测序结果在菌群组成变化上一致,但重复拭子的动态变化仅测序可检测。
核心结论
- 银屑病皮肤微生物组组成发生显著变化,尤其治疗期间的变化可能为发病机制提供新见解并预测治疗反应。
研究设计与样本
- 前瞻性观察研究,纳入23例银屑病患者和20例健康对照,采集皮损、非皮损及对照部位拭子,行16S rRNA测序和传统培养联合MALDI-TOF质谱分析。
主要发现
- 银屑病与厚壁菌门丰度增加和放线菌门相应减少相关,皮损处最明显,系统治疗期间至少部分逆转。
- 皮损部位细菌群落组成变化反映在可培养细菌的类似变化中,但重复拭子的微生物群变化仅测序可检测。
- 微生物群落组成随皮肤部位和微环境变化。
- 普雷沃菌属和葡萄球菌属与皮损显著相关,厌氧球菌属和丙酸杆菌属与非皮损显著相关。
- 健康对照与银屑病患者皮肤培养细菌量无显著差异。
临床怎么用
- 皮肤微生物组特征可能最终进入临床,辅助优化现有治疗并识别新的治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The treatment of psoriasis has been revolutionized by the development of biologic therapies. However, the pathogenesis of psoriasis, in particular the role of the cutaneous microbiome, remains incompletely understood. Moreover, skin microbiome studies have relied heavily on 16S rRNA sequencing data in the absence of bacterial culture. OBJECTIVES: To characterize and compare the cutaneous microbiome in 20 healthy controls and 23 patients with psoriasis using metagenomic analyses and to determine changes in the microbiome during treatment. METHODS: Swabs from lesional and nonlesional skin from patients with psoriasis, and from controls matched for site and skin microenvironment, were analysed using both 16S rRNA sequencing and traditional culture combined with mass spectrometry (MALDI-TOF) in a prospective study. RESULTS: Psoriasis was associated with an increased abundance of Firmicutes and a corresponding reduction in Actinobacteria, most marked in lesional skin, and at least partially reversed during systemic treatment. Shifts in bacterial community composition in lesional sites were reflected in similar changes in culturable bacteria, although changes in the microbiota over repeated swabbing were detectable only with sequencing. The composition of the microbial communities varied by skin site and microenvironment. Prevotella and Staphylococcus were significantly associated with lesional skin, and Anaerococcus and Propionibacterium with nonlesional skin. There were no significant differences in the amount of bacteria cultured from the skin of healthy controls and patients with psoriasis. CONCLUSIONS: Shifts in the cutaneous microbiome in psoriasis, particularly during treatment, may shed new light on the pathogenesis of the disease and may be clinically exploited to predict treatment response. What's already known about this topic? Alterations in the composition of the cutaneous microbiome have been described in psoriasis, although methodological differences in study design prevent direct comparison of results. To date, most cutaneous microbiome studies have focused on 16S rRNA sequencing data, including both living and dead bacteria. What does this study add? This prospective observational study confirms that changes in the composition of the cutaneous microbiome, detected by 16S rRNA sequencing, are consistent with those identified by bacterial culture and mass spectrometry. The changes in the microbiome during antipsoriasis therapy should be further investigated to determine whether these represent potential novel biomarkers of treatment response. What is the translational message? Characterization of cutaneous microbiota may ultimately move into the clinic to help facilitate treatment selection, not only by optimizing currently available treatments, but also by identifying new therapeutic targets.
引用
- Langan EA, Künstner A, Miodovnik M, et al. Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis. Br J Dermatol. 2019. PMID: 30985920. doi:10.1111/bjd.17989
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。